Loading…
www.soma4ever.com, a Singapore-based website, was found to be illegally selling unapproved and misbranded opioids, benzodiazepines, and Schedule II stimulants to U.S. consumers via the internet in violation of sections 301(a), 301(d), 301(k), 503(b), and 505(a) of the Federal Food, Drug, and Cosmetic Act. The company failed to obtain FDA approval for these drug products before introducing them into interstate commerce and did not comply with proper labeling and marketing requirements. The FDA emphasized the significant public health risks posed by the unlawful online distribution of these controlled substances, particularly given the ongoing opioid epidemic and the dangers of benzodiazepine and stimulant abuse and diversion.